Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R. Chandrasekhar J, et al. Among authors: gabriel steg p. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E217-E225. doi: 10.1002/ccd.26716. Epub 2016 Sep 21. Catheter Cardiovasc Interv. 2017. PMID: 27650638
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
Velders MA, Abtan J, Angiolillo DJ, Ardissino D, Harrington RA, Hellkamp A, Himmelmann A, Husted S, Katus HA, Meier B, Schulte PJ, Storey RF, Wallentin L, Gabriel Steg P, James SK; PLATO Investigators. Velders MA, et al. Among authors: gabriel steg p. Heart. 2016 Apr;102(8):617-25. doi: 10.1136/heartjnl-2015-308963. Epub 2016 Feb 4. Heart. 2016. PMID: 26848185 Clinical Trial.
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L; Dual Antiplatelet Therapy Study Investigators. Resor CD, et al. Among authors: gabriel steg p. Circulation. 2016 Oct 4;134(14):989-998. doi: 10.1161/CIRCULATIONAHA.116.024531. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576774 Free PMC article. Clinical Trial.
[Aspirin and prevention of cardiovascular risk].
Karila-Cohen D, Gabriel Steg P. Karila-Cohen D, et al. Among authors: gabriel steg p. Rev Med Interne. 2000 Mar;21 Suppl 1:35s-40s. doi: 10.1016/s0248-8663(00)88723-8. Rev Med Interne. 2000. PMID: 10763203 Review. French.
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score.
Fox KA, Fitzgerald G, Puymirat E, Huang W, Carruthers K, Simon T, Coste P, Monsegu J, Gabriel Steg P, Danchin N, Anderson F. Fox KA, et al. Among authors: gabriel steg p. BMJ Open. 2014 Feb 21;4(2):e004425. doi: 10.1136/bmjopen-2013-004425. BMJ Open. 2014. PMID: 24561498 Free PMC article.
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease.
Bouabdallaoui N, Messas N, Greenlaw N, Ferrari R, Ford I, Fox KM, Tendera M, P Naidoo D, Hassager C, Gabriel Steg P, Tardif JC; CLARIFY Investigators. Bouabdallaoui N, et al. Among authors: gabriel steg p. Eur J Prev Cardiol. 2021 Oct 25;28(13):1460-1466. doi: 10.1177/2047487320918728. Epub 2020 Apr 27. Eur J Prev Cardiol. 2021. PMID: 34695217
Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis.
Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard PM, Costagliola D, Cohen A; Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators. Boccara F, et al. Among authors: gabriel steg p. Eur Heart J. 2011 Jan;32(1):41-50. doi: 10.1093/eurheartj/ehq372. Epub 2010 Oct 21. Eur Heart J. 2011. PMID: 20965887
[No title available]
[No authors listed] [No authors listed] PMID: 32340463
Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
Schwartz GG, Gabriel Steg P, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Jukema JW, Kim YU, Li QH, Manvelian G, Pordy R, Sourdille T, White HD, Szarek M; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. Among authors: gabriel steg p. Circulation. 2021 Mar 16;143(11):1109-1122. doi: 10.1161/CIRCULATIONAHA.120.049447. Epub 2021 Jan 13. Circulation. 2021. PMID: 33438437 Free PMC article. Clinical Trial.
24 results